Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma
Anticancer Research · 2026
DOI: 10.21873/anticanres.18120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Elizabeth D Cochran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, U.S.A. Hauptthemen laut MEDLINE: Neuroblastoma, RNA-Binding Proteins, Drug Resistance, Neoplasm, Nerve Tissue Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, U.S.A.
- Division of Pediatric Surgery, Children's Health, Dallas, TX, U.S.A.
- Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, U.S.A.; dai.chung@utsouthwestern.edu.
Zitieren
APA
Cochran, E. D., Qiao, J., Machchhar, A., Jacobson, J. C., McCreery, S., & Chung, D. H. (2026). Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma. Anticancer Research. https://doi.org/10.21873/anticanres.18120
Vancouver
Cochran ED, Qiao J, Machchhar A, Jacobson JC, McCreery S, Chung DH. Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma. Anticancer Research. 2026. doi:10.21873/anticanres.18120
BibTeX
@article{Cochran2026,
author = {Cochran, Elizabeth D and Qiao, Jingbo and Machchhar, Arti and Jacobson, Jillian C and McCreery, Sullivan and Chung, Dai H},
title = {Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18120}
}
EUVIMED